Tower Research Capital (TRC)’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $5.81K | Sell |
|
|||||
|
2023
Q4 | $10K | Sell |
|
|||||
|
2023
Q3 | $29.9K | Buy |
|
|||||
|
2023
Q2 | $10.5K | Sell |
|
|||||
|
2023
Q1 | $19K | Buy |
|
|||||
|
2022
Q4 | $16K | Sell |
|
|||||
|
2022
Q3 | $74K | Buy |
|
|||||
|
2022
Q2 | $29K | Buy |
|
|||||
|
2022
Q1 | $16K | Buy |
|
|||||
|
2021
Q4 | $13K | Sell |
|
|||||
|
2021
Q3 | $131K | Buy |
|
|||||
|
2021
Q2 | $55K | Buy |
|
|||||
|
2021
Q1 | $49K | Buy |
|
|||||
|
2020
Q4 | $37K | Sell |
|
|||||
|
2020
Q3 | $98K | Buy |
|
|||||
|
2020
Q2 | $77K | Buy |
|
|||||
|
2020
Q1 | $16K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $16K | Buy |
|